Insulin resistance is associated with increased circulating levels of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients. - Hori,Y.; Gabazza,EC.; Yano,Y.; Katsuki,A.; Suzuki,K.; Adachi,Y. (J Clin Endocrinol Metab, 2002)